John Finnie Selected Research

John Finnie Research Topics

2	Nervous System Diseases (Neurological Disorders) 01/2022 - 01/2019
2	Infections 11/2021 - 01/2015
2	Mucositis 01/2017 - 01/2007
2	Colorectal Neoplasms (Colorectal Cancer) 01/2013 - 01/2007
2	Mucopolysaccharidosis VI (Syndrome, Maroteaux-Lamy) 01/2012 - 02/2010
1	Sinusitis 11/2021
1	Aortic Rupture 10/2021
1	Rupture 10/2021
1	Aortic Root Aneurysm 09/2021
1	Fibrosis (Cirrhosis) 09/2021
1	Ascending Aorta Aneurysm 09/2021
1	Autolysis 08/2021
1	Retinal Detachment (Retinal Detachments) 08/2021
1	Ganglion Cysts (Ganglion) 08/2021
1	Vesicular Stomatitis 01/2021
1	Cystic Fibrosis (Mucoviscidosis) 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Diarrhea 01/2019
1	Inflammation (Inflammations) 01/2019
1	Amyloid Plaque 01/2017
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Gliosis 01/2017
1	Disease Progression 01/2017
1	HIV Infections (HIV Infection) 09/2014
1	Neoplasm Metastasis (Metastasis) 01/2013
1	Paresis (Hemiparesis) 01/2012
1	Human Influenza (Influenza) 05/2011
1	Myocarditis (Carditis) 11/2008
1	Cardiomyopathies (Cardiomyopathy) 11/2008
1	Zellweger Syndrome (Zellweger's Syndrome) 08/2003

3	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 01/2007
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2003
2	Retinaldehyde (Retinal)IBA 08/2021 - 01/2017
2	CytokinesIBA 01/2019 - 01/2017
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	Neurofilament ProteinsIBA 01/2022
1	AntibodiesIBA 01/2022
1	UbiquitinIBA 01/2022
1	SynaptophysinIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2021
1	CollagenIBA 09/2021
1	ElastinIBA 09/2021
1	Fixatives (Pickling Agents)IBA 08/2021
1	Formaldehyde (Formol)FDA Link 08/2021
1	LuciferasesIBA 01/2021
1	neratinibIBA 01/2019
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2019
1	ChemokinesIBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	EnzymesIBA 01/2019
1	GalactosidasesIBA 01/2019
1	Galactosylceramides (Galactocerebrosides)IBA 01/2019
1	Colesevelam Hydrochloride (Welchol)FDA Link 01/2019
1	Psychosine (Galactosylsphingosine)IBA 01/2019
1	Cell Adhesion MoleculesIBA 01/2017
1	E-SelectinIBA 01/2017
1	Nucleic AcidsIBA 01/2015
1	N-(4-aminophenethyl)spiroperidol (NAPS)IBA 01/2015
1	REP 2055IBA 01/2015
1	Antiviral Agents (Antivirals)IBA 01/2015
1	Therapeutic UsesIBA 01/2015
1	Saline SolutionIBA 01/2015
1	PolymersIBA 01/2015
1	Broadly Neutralizing AntibodiesIBA 09/2014
1	N-Acetylgalactosamine-4-Sulfatase (Arylsulfatase B)IBA 01/2012
1	GlycosaminoglycansIBA 01/2012
1	alpha-galactosylceramideIBA 05/2011
1	VaccinesIBA 05/2011
1	Peptides (Polypeptides)IBA 05/2011
1	Protein Subunit VaccinesIBA 05/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2008
1	Cytotoxins (Cytolysins)IBA 01/2007

2	Therapeutics 11/2021 - 01/2020
1	Phage Therapy 11/2021
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 10/2021
1	Sternotomy 10/2021
1	Bronchoscopes 01/2021
1	Drug Therapy (Chemotherapy) 01/2017
1	Aftercare (After-Treatment) 01/2015
1	Spinal Injections 02/2010